Pemigatinib Combined With Durvalumab for Previously Treated Biliary Tract Carcinoma
Pemigatinib Combined With Durvalumab for Previously Treated Biliary Tract Carcinoma
Not yet recruiting · NCT06530823 · Registry updated 2024-07-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pemigatinib Combined With Durvalumab for Previously Treated Biliary Tract Carcinoma | Neoplasms by Histologic Type, adenocarcinoma, carcinoma, cholangiocarcinoma, epithelial neoplasm, neoplasm | Not yet recruiting | Phase 2 | 2024-07-31 | NCT06530823 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eastern Hepatobiliary Surgery Hospital | 22 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||